The requirements for analytical method validation which are listed in “ANVISA RDC 166/2017-Validation of Analytical Methods” and “ANVISA RDC 53/2015- Guide on notification, identification, and qualification of degradation products in medicinal products,” and are going beyond those defined in ICH Q2(R1), FDA guidance for Industry and relevant chapters of USP, EP and JP are summarized…